WAT launches the BD FACSDiscover A7 globally, bringing advanced spectral flow cytometry, automation and standardized workflows to research labs.

Shares of BioAffinity Technologies Inc. BIAF are surging Thursday afternoon following the grant of a key Hong Kong patent for ...

Tuberculosis (TB) remains one of the world's leading causes of death, and preventing post-treatment relapse continues to be a ...

The FACSDiscover A7 Cell Analyzer sets a new standard for experimental standardization in flow cytometry Waters Corporation ...

Global Life Science and Chemical Instrumentation Market was valued at USD 64.20 Billion in 2025 and is expected to grow at 7.2% CAGR to reach USD 128.40 Billion by 2035.

Multiparametric flow cytometry—a test that is widely accessible, cost-effective and timely—can find one cancerous cell hidden ...

Rutgers Cancer Institute Showcases Research Shaping the Future of Cancer Care / Ankit Saxena, cancer, gastric cancer, Haejin ...

Proprietary TeloView® blood-based TELO-MRD assay detected residual myeloma cells in a higher proportion of matched samples than bone-marrow next-generation flow cytometry in a University of Athens ...

Waters Corporation announced the global commercial launch of the BD FACSDiscover A7 Cell Analyzer, which uniquely combines exceptional spectral resolution and sensitivity with industry-leading ...

Waters Corporation (NYSE: WAT) today announced the global commercial launch of the BD FACSDiscover™ A7 Cell Analyzer, which uniquely combines exceptional spectral resolution and sensitivity with ...

Introduction Cell surface proteins are essential regulators of cell communication, mediating immune activation, cell adhesion ...

The new cell analyser expands Waters' category-defining FACSDiscover platform of flow cytometers, incorporating the same ...